MeSH term
Frequency | Condition_Probility | Apoptosis | 4 | 0.0 |
*Cell Cycle Proteins | 14 | 1.0 |
DNA Damage | 2 | 0.0 |
DNA Repair | 2 | 0.0 |
*DNA-Binding Proteins | 10 | 0.0 |
Humans | 31 | 0.0 |
Models, Biological | 3 | 0.0 |
Mutation | 3 | 0.0 |
*Nuclear Proteins | 6 | 0.0 |
Oxidative Stress | 2 | 0.0 |
Oxygen/metabolism | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Proteins/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Animals | 8 | 0.0 |
Female | 9 | 0.0 |
Male | 8 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Cell Line | 3 | 0.0 |
Fanconi Anemia/genetics | 2 | 16.0 |
Genetic Complementation Test | 5 | 0.0 |
Mitomycin/pharmacology | 6 | 6.0 |
Mutation/*genetics | 2 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Comparative Study | 2 | 0.0 |
Fanconi Anemia/*genetics/physiopathology | 2 | 66.0 |
Signal Transduction/physiology | 2 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Cell Cycle | 2 | 0.0 |
Child | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Mice | 3 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Acute Disease | 2 | 0.0 |
Adult | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
RNA-Binding Proteins/genetics/*metabolism | 3 | 4.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 3 | 1.0 |
Amino Acid Sequence | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Fanconi Anemia/*genetics | 4 | 8.0 |
Molecular Sequence Data | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Nuclear Proteins/genetics | 3 | 1.0 |
Alkylating Agents/pharmacology | 2 | 5.0 |
Cell Line, Tumor | 2 | 0.0 |
*DNA Methylation | 2 | 0.0 |
*Genes, BRCA1 | 3 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Exons | 3 | 0.0 |
Introns | 2 | 0.0 |
Aged | 3 | 0.0 |
DNA Methylation | 3 | 0.0 |
*Genes, BRCA2 | 3 | 1.0 |
Alleles | 3 | 0.0 |
RNA-Binding Proteins/*genetics | 2 | 1.0 |
DNA Mutational Analysis | 3 | 0.0 |
Genotype | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Drug Resistance, Neoplasm | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Ovarian Neoplasms/*drug therapy/*genetics | 2 | 66.0 |
Cells, Cultured | 2 | 0.0 |
Transfection | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |